Page 135 | Certara

Publication

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions,…

CertaraAugust 22, 2020

Case Study

Arvinas Selects Certara’s D360 to Advance Speed and Efficiency of Discovery Research

In February 2020, we announced that Certara’s discovery research relationship with Arvinas had expanded to…

CertaraAugust 21, 2020

Fact Sheet

Regulatory Operations and Submission Leadership

Expert support across the submission lifecycle, using advanced eCTD technology to accelerate timelines, reduce risk,…

CertaraAugust 13, 2020

Fact Sheet

Scientific and Medical Communications

CertaraAugust 13, 2020

Blog

Formatting Annotated Case Report Forms (aCRFs): Part 1

Discover essential tips for formatting aCRFs with clarity and regulatory compliance in mind. Read the…

CertaraAugust 12, 2020

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

CertaraAugust 7, 2020

On-Demand Webinar

Best Practices for Annotated CRFs

In this webinar, Amy Garrett reviews published guidance from regulatory agencies and provides best practices…

CertaraJuly 30, 2020

Publication

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…

CertaraJuly 26, 2020

Publication

Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19

We hypothesized that viral kinetic modeling could be helpful to prioritize rational drug combinations for…

CertaraJuly 26, 2020

Press Coverage

PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue

CertaraJuly 20, 2020

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

Arvinas Selects Certara’s D360 to Advance Speed and Efficiency of Discovery Research

Regulatory Operations and Submission Leadership

Scientific and Medical Communications

Formatting Annotated Case Report Forms (aCRFs): Part 1

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

Best Practices for Annotated CRFs

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19

PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue

Newsletter sign up

Quick links

Solutions

Contact